80% of women experience hormonal transition symptoms. 75% never receive treatment. The result: misattributed ER visits, unnecessary referrals, and avoidable claims. MARKABLE surfaces wellness patterns that may indicate emerging needs, before they escalate.
Unmanaged hormonal transitions generate avoidable claims across multiple cost categories. Here is what the numbers look like for a typical regional health plan.
Monitoring hormonal transitions today requires a doctor visit, a blood draw, insurance authorization, transportation, and time off work. MARKABLE requires a smartphone and 10 minutes.
Enter your plan's demographics below to see a custom cost avoidance estimate for proactive hormonal wellness monitoring.
MARKABLE fuses facial biomarker analysis, cognitive performance testing, and structured symptom capture into a single longitudinal wellness profile per member.
AI analysis of dermal, periorbital, and volumetric patterns associated with hormonal change. Smartphone camera, ~2 min.
Micro-tasks measuring attention, memory, and processing speed. Calibrated to functions sensitive to hormonal fluctuations. ~5 min.
70+ symptom domains with algorithm-driven pattern detection. Surfaces correlations that self-report alone cannot reveal. ~3 min.
Positioned as a general wellness product in accordance with FDA, MHRA (UK), and Israeli MOH guidelines. Not a medical device. Research methodology documentation available under NDA.
MARKABLE is offered on a PMPM basis, typically ranging from $0.50-$1.50 depending on plan size and engagement targets.
We track: member engagement rates, symptom burden reduction, treatment initiation rates, and claims impact. Quarterly reports provided.
Yes. We offer API integration and can feed wellness alerts into existing care management workflows.
We offer flexible models including PMPM (per member per month), per-use, and pilot-based pricing. Contact us for a custom proposal based on your member population and use case.
For initial pilots, no integration is needed. Members access MARKABLE via a web link. For scaled deployments, we offer API access and can discuss FHIR/HL7 integration pathways with your technical team.
Our platform was developed and tested on a 264-participant research dataset across three hormonal status groups. We can share our research summary and methodology documentation under NDA. Prospective validation studies are in planning.
The member owns their data. Health plans receive only aggregate, de-identified population insights. Individual-level data is never shared without explicit member consent.
MARKABLE is positioned as a general wellness product for personal awareness and monitoring. It does not require FDA clearance under current guidelines for general wellness products. It does not diagnose, treat, cure, or prevent any disease.
Yes. We offer structured pilot programs with defined cohorts, success metrics, and timeline. Typical pilot: 200-500 members, 3-6 months, with a dedicated success manager.
We'll analyze your member demographics and estimate the impact of proactive hormonal wellness monitoring.